Latest Biotech News

GSK outlined plans for five phase 3 studies for a gynecological cancer antibody-drug conjugate (ADC) licensed from Hansoh Pharma, after sharing early positive data. The company’s expansion to...

Two neuroscience and hematology-focused companies pushed IPO momentum as Seaport Therapeutics and Hemab Therapeutics filed for listings, with Kailera expected to price soon. The filings add to...

Researchers reported a high-throughput strategy targeting MDM2 to overcome radiation resistance in uveal melanoma, aiming at one of the central barriers to durable responses. The approach focuses...

Researchers unveiled allogeneic CD19 CAR T cells engineered with an anti-rejection CD70 CAR to address two key hurdles: antigen escape and alloimmune rejection. The concept combines an attack...

A new diagnostic imaging technique using lacrimal gland color Doppler ultrasonography could move Sjögren’s syndrome detection earlier, according to researchers behind the approach. The report...

Two separate Parkinson’s-focused technology updates moved machine learning and deep learning toward practical clinical use. One study reported a machine learning method to classify people with...

A development-focused report argues that improving preclinical-to-clinical translation requires more than candidate selection—it depends on how safety and predictability data are generated. It...

A report says CDC leadership delayed the release of an analysis intended to show COVID vaccines reduced severe illness, after acting CDC director Dr. Jay Bhattacharya raised concerns about...

Relacorilant (Lifyorli) plus nab-paclitaxel delivered a survival benefit in platinum-resistant ovarian cancer, with final overall survival results from the phase 3 ROSELLA study (NCT05257408)...

GSK moved to expand late-stage development of its gynecological cancer antibody-drug conjugate (ADC) licensed from Hansoh Pharma, outlining a plan for five Phase 3 studies. The update follows...

Researchers reported a dual-engineering strategy for allogeneic CD19 CAR T cells designed to address both antigen escape and alloimmune rejection. The approach adds an anti-rejection CD70 CAR...

A new high-throughput strategy targeting MDM2 aims to overcome radiation resistance in uveal melanoma, a malignancy where treatment durability remains a core challenge. The work outlines a...

The spring IPO market showed new momentum as Boston-based Avalyn Pharma filed an S-1 to support development of respiratory disease treatments, with multiple inhaled programs tied to pulmonary...

A Perspective piece reframed genomic sequencing’s next industry milestone around accessibility rather than only scaling throughput, usability, and integration. The report argues that sequencing...

Researchers unveiled a new early diagnostic approach for Sjögren’s syndrome using lacrimal gland color Doppler ultrasonography, aiming to detect the autoimmune disease earlier than conventional...

Two separate advances highlighted the growing use of AI in Parkinson’s diagnostics, ranging from lab-grade imaging algorithms to ultrasound-driven grading. In one report, a machine learning...

A detailed explainer laid out why preclinical-to-clinical translation remains fragile and tied current efforts to regulatory plans to reduce animal reliance. The report noted that more than 90%...

Separately from clinical science, a report described intensifying enforcement around hospital contracting practices, including a DOJ lawsuit involving OhioHealth and NewYork-Presbyterian...

Avalyn Pharma has filed its registration statement for an initial public offering, signaling a renewed push of public-market capital into respiratory fibrosis drug development. The Boston-based...

Final overall survival results from the Phase 3 ROSELLA study show relacorilant plus nab-paclitaxel reduced the risk of death versus nab-paclitaxel alone in platinum-resistant ovarian cancer. The...